A. Marc Gillinov, MD

Appointed
1997

Education & Fellowships

Fellowship - Johns Hopkins Hospital
Thoracic Surgery
Baltimore, MD
1997

Residency - Johns Hopkins Hospital
Thoracic Surgery
Baltimore, MD
1996

Residency - Johns Hopkins Hospital
General Surgery
Baltimore, MD
1994

Internship - Johns Hopkins Hospital
General Surgery
Baltimore, MD
1989

Medical Education - Johns Hopkins University School of Medicine
Baltimore, MD
1988

Undergraduate - Yale University
New Haven, CT
1984

Professional Highlights

• Co-author of "Heart 411: The Only Heart Guide You Will Every Need."
• Judith Dion Pyle Chair in Heart Valve Research
• Cleveland Clinic Innovator Award for New Techniques in Mitral Valve Repair
• Dr. Gillinov has one of the world's largest practices in robotic and minimally invasive mitral valve repair surgery

Certifications

• Thoracic Surgery - Thoracic and Cardiac Surgery

Specialty Interests

Mitral valve repair, robotic mitral valve surgery, robotic heart surgery, aortic valve replacement, minimally invasive heart surgery, heart valve surgery, heart valve repair, atrial fibrillation

Awards & Honors

• Chair, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic
• Board Member, Mitral Foundation
• Board Member, AATS Foundation
• 2024 - Program Chair, AATS
• 2019-present - Chair, NIH-Funded Cardiothoracic Surgery Trials Network, the world's largest research initiative in cardiac surgery
• 2022, 2023 - Mitral Valve Reference Center Award of Excellence as Reference Mitral Surgeon
• 2007-2023 - Best Doctors, Cleveland Magazine
• 2008 - present The Judith Dion Pyle Chair in Heart Valve Research
• 2007 - present Co-Principal Investigator, NIH Network for Cardiothoracic Surgical Investigations
• 2005 - present Principal Investigator, Atrial Fibrillation Innovation Center
• 2005, 2007 Cleveland Clinic Innovator Award for New Techniques in Mitral Valve Repair

Innovations & Patents

• Dr. Gillinov has been integral to the development of several new technologies in the management of heart disease. These include:Percutaneous mitral valve repair
• Automated creation of artificial chords for minimally invasive surgical mitral valve repair
• Left atrial appendage exclusion in atrial fibrillation
• Minimally invasive approaches to ablation of atrial fibrillation
• Novel technologies for minimally invasive surgical drainage systems

Memberships

• Key Memberships include:American Association for Thoracic Surgery
• Society of Thoracic Surgeons
• Heart Valve Society
• International Society for Minimally Invasive Cardiac Surgery

See publications for A. Marc Gillinov, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/4/2024, Dr. Gillinov has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Gillinov receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Baxter Healthcare Corporation
• Medtronic plc
• Abbott Laboratories
• Clear Catheter Systems, Inc.
• Edwards Lifesciences LLC

Royalty Payments. Dr. Gillinov receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Clear Catheter Systems, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Gillinov may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

• Clear Catheter Systems, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.